MobiHealth News August 29, 2019
Tel Aviv, Israel-based Biobeat has been granted 510(k) clearance for a remote monitoring device capable of measuring the wearer’s blood pressure, oxygenation and heart rate.
Designed for use in the hospital or at home, the device is available as either a wristwatch or adhesive patch. Of particular note, the products differentiate themselves from other remote monitoring devices through a photoplethysmography (PPG) approach that that sidesteps the need for an inflatable cuff.
“This is the first cuffless blood pressure solution to be cleared by the FDA — no more need for an inflating cuff,” Arik Ben Ishay, founder and CEO of Biobeat, said in a statement. “This clearance opens tremendous opportunities for remote monitoring of vital signs of patients and we...
Today's Sponsors
Today's Sponsor